Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


David C. Auth, Kirkland US

David C. Auth, Kirkland, WA US

Patent application numberDescriptionPublished
20080312646Transseptal closure of a patent foramen ovale and other cardiac defects - The present invention provides for therapeutic treatment methods, devices, and systems for the partial or complete closure or occlusion of a patent foramen ovale (“PFO”). In particular, various methods, devices, and systems for joining or welding tissues, in order to therapeutically close a PFO are described. In yet another aspect of the invention, various methods, devices, and systems for the penetration of the interatrial septum enabling left atrial access are also provided. 12-18-2008
20090093802Systems and Methods for Transeptal Cardiac Procedures, Including Tissue Penetrating Members and Associted Methods - Systems and methods for transeptal cardiac procedures are disclosed. A method for treating a patient in accordance with a particular embodiment includes positioning a tissue penetrating guidewire adjacent to a cardiac septum, directing pulses of energy to the guidewire, and advancing the guidewire into and through the septum by moving the guidewire in a distal direction in a series of discrete steps. Individual steps can be of a predetermined distance measured outside the patient's body. The method can further include passing a catheter over the guidewire after the guidewire has passed through the septum.04-09-2009
20090118725HEMOSTATIC TISSUE TUNNEL GENERATOR FOR INSERTING TREATMENT APPARATUS INTO TISSUE OF A PATIENT - A catheter for insertion into and treatment of tissue in a patient comprises a radio frequency (RF) electrode having an elongated body that conducts electrical RF energy to a conductive tip. An insulating sleeve surrounds the elongated body. In a first mode of operation, the conductive tip is exposed outside the insulating sleeve and the RF electrode delivers RF energy that erodes the tissue of the patient and creates a tunnel through which the catheter can advance into the tissue of the patient. In a second mode of operation, the insulating sleeve and/or the RF electrode is retracted and a second treatment apparatus treats the tissue.05-07-2009
20090118726Systems and Methods for Transeptal Cardiac Procedures, Including Tissue Sealing Members Associated Methods - Systems and methods for transeptal cardiac procedures are disclosed. A patient treatment device in accordance with a particular embodiment includes a catheter having a proximal end, a distal end, a working portion toward the distal end, and an electrical energy path coupleable to a source of electrical energy. The device can further include a tissue penetrating member carried by the catheter and an electrode device carried by the working portion of the catheter and movable along the tissue penetrating member. The electrode device can include a collapsible stranded conductive material coupled to the electrical signal path and being changeable between a deployed position and a stowed position. The conductive material can be elongated along a deployment axis when in the stowed position, and can be contracted along the deployment axis and expanded transverse to the deployment axis when in the deployed position.05-07-2009
20090118729HEMOSTATIC SPARK EROSION TISSUE TUNNEL GENERATOR WITH INTEGRAL TREATMENT PROVIDING VARIABLE VOLUMETRIC NECROTIZATION OF TISSUE - A catheter for insertion into and treatment of tissue in a patient comprises a radio frequency (RF) electrode having an elongated body that conducts electrical RF energy to a conductive tip. An insulating sleeve surrounding the elongated body prevents leakage of RF energy from the elongated body when the catheter is being inserted into the tissue of the patient. In a first mode of operation, the conductive tip is exposed outside the insulating sleeve and the RF electrode delivers first RF energy capable of producing sparks that erode the tissue of the patient and create a tunnel through which the catheter can advance into the tissue of the patient. In a second mode of operation, the insulating sleeve is retracted to expose a portion of the RF electrode. Second RF energy is delivered to the volume of tissue around the catheter to necrotize the tissue by heating without producing sparks.05-07-2009
20110087211TISSUE-PENETRATING GUIDEWIRES WITH SHAPED TIPS, AND ASSOCIATED SYSTEMS AND METHODS - Tissue-penetrating guidewires with shaped tips, and associated systems and methods are disclosed. A patient treatment system in accordance with one embodiment of the disclosure includes a tissue-penetrating guidewire that in turn includes a flexible segment having a distal portion and a proximal portion. The flexible segment is elongated along an elongation axis. A penetrating member is positioned at the distal portion and includes at least one blade segment having a tapered outer peripheral surface and an adjacent generally sharp edge. The blade segment extends to a distal end of the penetrating member to form a generally blunt tip. In operation, the guidewire can be connected to an electrical current source to deliver high frequency current to the penetrating member.04-14-2011
20110184330INACTIVATION OF SMOOTH MUSCLE TISSUE - Treatment and procedures for treating bodily conduits involves deactivating, killing, or otherwise treating smooth muscle tissue of the conduit.07-28-2011
20110208215DEVICES, METHODS, AND KITS FOR FORMING TRACTS IN TISSUE - Tissue tract-forming devices, methods, and kits are disclosed. In some variations, a method for forming a tract in a tissue wall having an interior surface and an exterior surface may comprise advancing an anchor member through the tissue wall and into a lumen defined by the tissue wall, the anchor member comprising a proximal portion, a distal portion, and an intermediate portion therebetween, wherein the proximal and intermediate portions are angled with respect to each other and the intermediate and distal portions are angled with respect to each other, positioning the anchor member so that the intermediate portion contacts the interior surface of the tissue wall and the distal portion is angled toward the interior surface of the tissue wall, and advancing a tissue-piercing member into the tissue wall while the intermediate portion is in contact with the interior surface of the tissue wall, to form a tract in the tissue wall.08-25-2011

Patent applications by David C. Auth, Kirkland, WA US